Abstract: 1112212345123412345Provided are a novel pest control agent composition and in particular a composition for a sterilising agent. A sterilising or bactericidal composition which contains: one or more compounds selected from oxime substituted amide compounds represented by formula (I) N oxides thereof and salts thereof; and one or more compounds selected from known sterilising or bactericidal compounds. [In the formula G represents a structure such as G 1 or G 27 G represents a structure such as G 2 W represents an oxygen atom or the like X represents difluoromethyl trifluoromethyl or the like X X X and X each independently represent a hydrogen atom or the like Y represents a halogen atom or the like Y represents a hydrogen atom a halogen atom or the like Y represents a halogen atom trifluoromethyl an alkynyl containing 2 6 carbon atoms or the like Y represents a hydrogen atom or the like R represents an alkyl containing 1 6 carbon atoms a haloalkyl containing 1 4 carbon atoms or the like R and R each independently represent a hydrogen atom a methyl or the like R represents a hydrogen atom or the like and R represents methyl or the like.]
TECHNICAL FIELD
The present invention relates to a novel composition for controlling plant diseases,
which comprises a specific oxime-substituted amide compound, or its N-oxide or salt,
and an active ingredient compound of a specific fungicidal or bactericidal agent, and a
method for controlling plant disease10 s.
BACKGROUND ART
An oxime-substituted amide compound represented by the formula (I), or its Noxide
or salt, as the first active ingredient compound in the fungicidal or bactericidal
15 composition of the present invention, is a known compound, and its activities as a
pesticidal agent have been known (see Patent Document 1).
Further, a compound being active ingredient B as the second active ingredient in
the fungicidal or bactericidal composition of the present invention, is a known compound
having fungicidal activities or bactericidal activities (see Non-Patent Document 1).
20
PRIOR ART DOCUMENTS
PATENT DOCUMENT
Patent Document 1: WO2014/010737
NON-PATENT DOCUMENT
25 Non-Patent Document 1: The Pesticide Manual, 16th edition, The British Crop
Protection Council, 2012
DISCLOSURE OF INVENTION
TECHNICAL PROBLEM
30 Plant diseases caused by infection of various pathogens on plants such as
cereals, fruits, vegetables, ornamental plants, etc., will cause deterioration of the quality
of agricultural crops, significant reduction in yield, and in some cases, even a serious
damage such as death of plants, and thus present a significant economic loss not only
to producers but also to consumers. Therefore, effective control of such plant diseases
35 is a very important issue, in order to achieve efficient and stable production of
agricultural crops. From this point of view, heretofore, developments of pest control
agents for the purpose of controlling plant diseases have been made, and many
effective pesticides have been put into practical use to date.
However, due to years of use of these pesticides, in recent years, there have been
40 an increasing number of cases where pathogens have acquired resistance to such
pesticides, and pest control by existing plant disease controlling agents which have
been used heretofore, tends to be difficult. In addition, such a problem has become
apparent that some of the existing plant disease control agents are highly toxic, or some
remain for a long time in the environment to create a problem of disrupting the
45 ecosystem. Under these circumstances, it is now consistently desired to develop a
new plant disease control agent which not only has excellent controlling activities
against pathogenic bacteria, but also has a high level of control characteristics such as
low toxicity and low residual properties, and an effective controlling method.
2
It is an object of the present invention to provide a novel plant disease control
agent which exhibits excellent controlling activities against pathogenic bacteria, and has
characteristics such as low toxicity and low residual properties, and a plant disease
control method.
5
SOLUTION TO PROBLEM
As a result of extensive research with an aim to solve the above problem, the
present inventors have found that a composition comprising, in combination, a specific
oxime-substituted amide compound represented by the following formula (I), or its Noxide
or salt (active ingredient A), and a specific compound having fungicidal o10 r
bactericidal activities (active ingredient BA), exhibits synergistic, excellent fungicidal or
bactericidal effects, which cannot be predicted from a case of using each compound
alone. That is, it has been found that the above composition is extremely useful in that
it shows excellent plant disease controlling activities and presents substantially no
15 adverse effects against non-target organisms such as plants, mammals, fish, useful
insects and natural enemies, and thus, the present invention has been accomplished.
That is, the present invention provides, as its gist, a composition as defined in the
following [1] to [19] (hereinafter referred to also as the composition of the present
invention), and a disease control method as defined in the following [20] (hereinafter
20 referred to also as the method of the present invention).
[1] A composition for a fungicide, an insecticide, a nematicide or a bactericide,
characterized by comprising one or more compounds selected from the following active
ingredient A, and one or more compounds selected from the following active ingredient
B, respectively in synergistically effective amounts:
25 (1) Active ingredient A: an oxime-substituted amide compound represented by the
following formula (I), or its N-oxide or its salt,
in the formula, G1 represents a structure of G1-1, G1-2, G1-3, G1-7, G1-8, G1-9, G1-11,
G1-12, G1-13, G1-16, G1-27, G1-32, G1-33 or G1-50,
W
C
N
R4
R2 R3
G2
N
G1
O
R1
(I)
3
G2 represents a structure of G2-1, G2-2, G2-6 or G2-9,
W represents an oxygen atom or a sulfur atom,
X1 represents a halogen atom, nitro, methyl, difluoromethyl or trifluoromethyl,
X2 represents a hydrogen atom, and further when G1 represents a structure of
G1-27, and X1 represents trifluoromethyl, X2 may represent a halogen atom5 ,
X3 represents a hydrogen atom or methyl,
X4 represents a hydrogen atom or a halogen atom,
X5 represents a hydrogen atom,
Y1 represents a hydrogen atom, a halogen atom, methyl, trifluoromethyl or
10 methoxy,
Y2 represents a hydrogen atom, a halogen atom, cyano, methoxy, methylthio,
methylsulfinyl or methylsulfonyl,
Y3 represents a hydrogen atom, a halogen atom, cyano, C1-C4 alkyl,
trifluoromethyl, C2-C4 alkenyl, C2-C6 alkynyl, (C2-C6) alkynyl optionally substituted by R6,
15 -OR7, C1-C4 alkylthio, -C(R8)=NOR9, phenyl, D-3 or D-7,
Y4 represents a hydrogen atom or a halogen atom,
Y5 represents a hydrogen atom,
X1
G1-1
N
X1
G1-2
N
X1
G1-3 G1-7
N
X1
G1-16
N
N
X1
G1-27
S
N
X1
G1-32
N
S
X1
G1-33
X2
X5
X4
X3
X2 X4
X3
X4
X3
N
N
X1
X5
X2
R5 X2
X4
X3
S
X1
G1-12
X3
S
X1
G1-13
X2
R5
S
X1
G1-11
X4
X3 X2
X4
X4
O
X1
G1-8
O
X1
G1-9
X4
X3 X3 X2
X3 X3
G1-50
O
S
X1
(O)r
Y1
Y2
Y3
Y4
Y5
N
Y1
Y2
Y3
Y4
G2-1 G2-2 G2-6
S
Y1
G2-9
Y3
N
Y1 N Y3
Y4
Y2
4
R1 represents C1-C6 alkyl, C1-C4 haloalkyl, (C1-C4) alkyl substituted by R10, C3-C6
cycloalkyl, C3-C6 alkenyl, C3-C4 haloalkenyl, C3-C6 alkynyl or phenyl,
R2 represents a hydrogen atom, methyl or ethyl, provided that R2 represents
methyl or ethyl when G1 represents a structure of G1-1, X1 represents a chlorine atom,
X2, X3 and X5 each represents a hydrogen atom, X4 represents a hydrogen atom or 5 a
chlorine atom, and G2 represents a structure of G2-1, Y3 represents a chlorine atom, Y1,
Y2, Y4 and Y5 each represents a hydrogen atom,
R3 represents a hydrogen atom or methyl, or R2 and R3 may together form a
cyclopropyl ring,
10 R4 represents a hydrogen atom, C1-C4 haloalkylthio, C1-C4 alkylcarbonyl or C1-C4
alkoxycarbonyl,
R5 represents methyl,
R6 represents a halogen atom, C3-C6 cycloalkyl, hydroxy(C3-C6)cycloalkyl, C5-C6
cycloalkenyl, -OH, -OR7, C1-C4 alkylcarbonyloxy, C1-C4 alkylsulfonyloxy, C1-C4 alkylthio,
15 trimethylsilyl, -C(R8)=NOR9, phenyl, phenyl substituted by (Z)m or D-32,
Z represents a halogen atom, cyano, nitro, C1-C4 alkyl, trifluoromethyl, methoxy,
trifluoromethoxy, trifluoromethylthio or phenyl, and when m or n represents 2 or more,
the respective Z’s may be identical with or different from one another, and when there
are two neighboring Z’s, the two neighboring Z’s may form -CH=CH-CH=CH- to form a
20 6-membered ring together with the carbon atoms attached to the two Z’s,
R7 represents C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy(C1-C2)alkyl, E-14, C3-C4
alkynyl or phenyl substituted by (Z)m,
R8 represents a hydrogen atom or methyl,
R9 represents methyl or ethyl,
25 R10 represents cyano, C3-C6 cycloalkyl, E-5, E-9, C1-C4 alkoxy, C1-C4 alkylthio,
trimethylsilyl, -C(R11)=NOR12, phenyl, phenyl substituted by (Z)m, D-10 or D-32,
D-3, D-7, D-10 and D-32, respectively, represent aromatic heterocyclic rings of the
following structural formulae,
E-5, E-9 and E-14, respectively, represent saturated heterocyclic rings of the
30 following structural formulae,
R11 represents methyl,
R12 represents methyl or ethyl,
m represents an integer of 1, 2 or 3,
n represents an integer of 0, 1 or 2,
35 (2) active ingredient B:
B-I group: benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M, ofurace,
D-3
N
(Z)n
D-7
N
N
(Z)n
D-10
N
S
(Z)n
D-32
N
(Z)n
E-5
O
E-9
O
O O
E-14
5
oxadixyl, bupirimate, ethirimol, hymexazol, octhilinone and oxolinic acid,
B-II group: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanatemethyl,
diethofencarb, ethaboxam, zoxamide, pencycuron, fluopicolide, diflumetorim
and benodanil,
B-III group: benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram5 ,
flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil, oxycarboxin,
penflufen, penthiopyrad, sedaxane, thifluzamide, azoxystrobin, coumoxystrobin,
dimoxystrobin, enestrobin, enoxastrobin, famoxadone, fenamidone, fenaminstrobin,
flufenoxystrobin, fluoxastrobin, kresoxim-methyl, mandestrobin, metominostrobin,
10 orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin,
pyribencarb-methyl, pyriminostrobin, triclopyricab, trifloxystrobin, amisulbrom,
cyazofamid, dinocap, fluazinam, meptyldinocap, fentin, tributyltin oxide, silthiofam and
ametoctradin,
B-IV group: cyprodinil, mepanipyrim, pyrimethanil, blasticidin-S, kasugamycin,
15 streptomycin and oxytetracycline,
B-V group: proquinazid, quinoxyfen, fenpiclonil, fludioxonil and chlozolinate,
B-V group: iprodione, procymidone and vinclozolin,
B-VI group: edifenphos, iprobenfos, isoprothiolane, pyrazophos, biphenyl,
chloroneb, dicloran, etridiazole, quintozene, tecnazene, tolclofos-methyl, propamocarb
20 hydrochloride and Bacillus subtilis (Strain: D747, FZB24, GBO3, HAI0404, MBI600,
QST713, Y1336, etc.),
B-VII group: azaconazole, bitertanol, bromuconazole, climbazole, cyproconazole,
diclobutrazol, difenoconazole, diniconazole, diniconazole-M, epoxiconazole,
etaconazole, fenarimol, fenbuconazole, fluotrimazole, fluquinconazole, flusilazole,
25 flutriafol, furconazole, hexaconazole, imazalil, imibenconazole, ipconazole,
metconazole, myclobutanil, nuarimol, oxpoconazole fumarate, pefurazoate,
penconazole, prochloraz, propiconazole, prothioconazole, pyrifenox, pyrisoxazole,
simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole,
triforine, triticonazole, aldimorph, dodemorph acetate, fenpropidin, fenpropimorph,
30 piperalin, spiroxamine, tridemorph, fenhexamid and fenpyrazamine,
B-VIII group: validamycin, polyoxins, polyoxorim, benthiavalicarb-isopropyl,
dimethomorph, flumorph, iprovalicarb, mandipropamid, pyrimorph and valifenalate,
B-IX group: phthalide, pyroquilon, tricyclazole, carpropamid, diclocymet and
fenoxanil,
35 B-X group: acibenzolar-S-methyl, probenazole, isotianil and tiadinil,
B-XI group: laminarin, bordeaux mixture, cheshunt mixture, copper carbonate
basic, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride,
copper sulfate, basic copper sulfate, oxine copper, calcium polysulfide, sulfur, amobam,
ferbam, mancozeb, maneb, metiram, polycarbamate, propineb, thiram, ziram, captan,
40 folpet, chlorothalonil, dichlofluanid, tolylfluanid, guazatine, iminoctadine-albesilate,
iminoctadine- triacetate, anilazine, dithianon, chinomethionat and fluoroimide,
B-XII group: cyflufenamid, cymoxanil, diclomezine, dodine, ferimzone,
flusulfamide, flutianil, fosetyl-aluminium, metrafenone, oxathiapiprolin, pyriofenone,
tebufloquin, tolprocarb, triazoxide, potassium hydrogen carbonate, sodium hydrogen
45 carbonate, shiitake mycelium extract, shiitake fruiting body extract, BCF-082 (test
name) and NNF-0721 (test name).
[2] The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to the above [1], wherein
6
G1 represents a structure of G1-1, G1-2, G1-3, G1-7, G1-11, G1-12, G1-16, G1-27 or
G1-33,
G2 represents a structure of G2-1, G2-2 or G2-9,
W represents an oxygen atom,
X1 represents a halogen atom, methyl, difluoromethyl or trifluoromethyl5 ,
X2 represents a hydrogen atom,
X3 represents a hydrogen atom or methyl,
X4 represents a hydrogen atom,
X5 represents a hydrogen atom,
10 Y1 represents a halogen atom,
Y2 represents a hydrogen atom, a halogen atom, methoxy, methylthio or
methylsulfonyl,
Y3 represents a halogen atom, trifluoromethyl, C2-C4 alkenyl, C2-C6 alkynyl, (C2-
C6) alkynyl optionally substituted by R6, C1-C4 haloalkoxy or -C(R8)=NOR9,
15 Y4 represents a hydrogen atom or a halogen atom,
Y5 represents a hydrogen atom,
R1 represents C1-C6 alkyl, C1-C4 haloalkyl, (C1-C4) alkyl substituted by R10, C3-C6
cycloalkyl, C3-C6 alkenyl, C3-C4 haloalkenyl or C3-C6 alkynyl,
R2 represents a hydrogen atom or methyl, provided that when G2 is a structure
20 represented by G2-1, R2 represents methyl,
R3 represents a hydrogen atom,
R4 represents a hydrogen atom,
R5 represents methyl,
R6 represents a halogen atom, C3-C6 cycloalkyl, -OR7, trimethylsilyl, -C(R8)=NOR9
25 or phenyl,
R7 represents C1-C4 alkyl or C1-C4 alkoxymethyl,
R10 represents C3-C6 cycloalkyl, trimethylsilyl, phenyl, phenyl substituted by (Z)m,
or D-32,
Z represents a halogen atom or cyano, and when m represents 2 or more, the
30 respective Z’s may be identical with or different from one another,
n represents an integer of 1.
[3] The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to the above [1] or [2], wherein
G1 represents a structure of G1-1, G1-3, G1-27 or G1-33,
35 G2 represents a structure of G2-2,
X1 represents a chlorine atom, an iodine atom, difluoromethyl or trifluoromethyl,
X2 represents a hydrogen atom,
X3 represents a hydrogen atom or methyl,
X4 represents a hydrogen atom,
40 X5 represents a hydrogen atom,
Y1 represents a chlorine atom or a bromine atom,
Y2 represents a hydrogen atom, a chlorine atom or methoxy,
Y3 represents a chlorine atom, a bromine atom, trifluoromethyl, C2-C6 alkynyl, or
(C2-C6) alkynyl optionally substituted by R6,
45 Y4 represents a hydrogen atom,
R1 represents C1-C4 alkyl, C1-C4 haloalkyl or cyclopropylmethyl,
R2 represents a hydrogen atom or methyl,
R3 represents a hydrogen atom,
1. A composition for a fungicide, an insecticide, a nematicide or a bactericide,
comprising synergistically effective amounts of at least two types of the following
compounds, which is a composition for a fungicide, an insecticide, a nematicide or a
bactericide, comprising one or more compounds selected from the following activ5 e
ingredient A, and one or more compounds selected from active ingredient B-I group to
B-XII group in the following active ingredient B:
(1) Active ingredient A: an oxime-substituted amide compound represented by the
following formula (I), or its N-oxide or its salt,
W represents an oxygen atom or a sulfur atom,
X1 represents a halogen atom, nitro, methyl, difluoromethyl or trifluoromethyl,
X2 represents a hydrogen atom, and further when G1 represents a structure of
G1-27, and X1 represents trifluoromethyl, X2 may represent a halogen atom,
X3 represents a hydrogen atom or methyl5 ,
X4 represents a hydrogen atom or a halogen atom,
X5 represents a hydrogen atom,
Y1 represents a hydrogen atom, a halogen atom, methyl, trifluoromethyl or
methoxy,
10 Y2 represents a hydrogen atom, a halogen atom, cyano, methoxy, methylthio,
methylsulfinyl or methylsulfonyl,
Y3 represents a hydrogen atom, a halogen atom, cyano, C1-C4 alkyl,
trifluoromethyl, C2-C4 alkenyl, C2-C6 alkynyl, (C2-C6) alkynyl optionally substituted by R6,
-OR7, C1-C4 alkylthio, -C(R8)=NOR9, phenyl, D-3 or D-7,
15 Y4 represents a hydrogen atom or a halogen atom,
Y5 represents a hydrogen atom,
R1 represents C1-C6 alkyl, C1-C4 haloalkyl, (C1-C4) alkyl substituted by R10, C3-C6
cycloalkyl, C3-C6 alkenyl, C3-C4 haloalkenyl, C3-C6 alkynyl or phenyl,
R2 represents a hydrogen atom, methyl or ethyl, provided that R2 represents
20 methyl or ethyl when G1 represents a structure of G1-1, X1 represents a chlorine atom,
X2, X3 and X5 each represents a hydrogen atom, X4 represents a hydrogen atom or a
chlorine atom, and G2 represents a structure of G2-1, Y3 represents a chlorine atom, Y1,
Y2, Y4 and Y5 each represents a hydrogen atom,
R3 represents a hydrogen atom or methyl, or R2 and R3 may together form a
25 cyclopropyl ring,
R4 represents a hydrogen atom, C1-C4 haloalkylthio, C1-C4 alkylcarbonyl or C1-C4
alkoxycarbonyl,
R5 represents methyl,
R6 represents a halogen atom, C3-C6 cycloalkyl, hydroxy(C3-C6)cycloalkyl, C5-C6
30 cycloalkenyl, -OH, -OR7, C1-C4 alkylcarbonyloxy, C1-C4 alkylsulfonyloxy, C1-C4 alkylthio,
trimethylsilyl, -C(R8)=NOR9, phenyl, phenyl substituted by (Z)m or D-32,
Z represents a halogen atom, cyano, nitro, C1-C4 alkyl, trifluoromethyl, methoxy,
trifluoromethoxy, trifluoromethylthio or phenyl, and when m or n represents 2 or more,
the respective Z’s may be identical with or different from one another, and when there
35 are two neighboring Z’s, the two neighboring Z’s may form -CH=CH-CH=CH- to form a
6-membered ring together with the carbon atoms attached to the two Z’s,
R7 represents C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy(C1-C2)alkyl, E-14, C3-C4
alkynyl or phenyl substituted by (Z)m,
R8 represents a hydrogen atom or methyl,
40 R9 represents methyl or ethyl,
R10 represents cyano, C3-C6 cycloalkyl, E-5, E-9, C1-C4 alkoxy, C1-C4 alkylthio,
trimethylsilyl, -C(R11)=NOR12, phenyl, phenyl substituted by (Z)m, D-10 or D-32,
D-3, D-7, D-10 and D-32, respectively, represent aromatic heterocyclic rings of the
following structural formulae,
126
E-5, E-9 and E-14, respectively, represent saturated heterocyclic rings of the
following structural formulae,
R11 represents methyl,
R12 represents methyl or ethyl,
m represents an integer of 1, 2 or 35 ,
n represents an integer of 0, 1 or 2,
(2) active ingredient B: compound(s) selected from the following active ingredient
B-I group to B-XII group,
B-I group: benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M, ofurace,
10 oxadixyl, bupirimate, ethirimol, hymexazol, octhilinone and oxolinic acid,
B-II group: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanatemethyl,
diethofencarb, ethaboxam, zoxamide, pencycuron, fluopicolide, diflumetorim
and benodanil,
B-III group: benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram,
15 flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil, oxycarboxin,
penflufen, penthiopyrad, sedaxane, thifluzamide, azoxystrobin, coumoxystrobin,
dimoxystrobin, enestrobin, enoxastrobin, famoxadone, fenamidone, fenaminstrobin,
flufenoxystrobin, fluoxastrobin, kresoxim-methyl, mandestrobin, metominostrobin,
orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin,
20 pyribencarb-methyl, pyriminostrobin, triclopyricab, trifloxystrobin, amisulbrom,
cyazofamid, dinocap, fluazinam, meptyldinocap, fentin, tributyltin oxide, silthiofam and
ametoctradin,
B-IV group: cyprodinil, mepanipyrim, pyrimethanil, blasticidin-S, kasugamycin,
streptomycin and oxytetracycline,
25 B-V group: proquinazid, quinoxyfen, fenpiclonil, fludioxonil and chlozolinate,
B-V group: iprodione, procymidone and vinclozolin,
B-VI group: edifenphos, iprobenfos, isoprothiolane, pyrazophos, biphenyl,
chloroneb, dicloran, etridiazole, quintozene, tecnazene, tolclofos-methyl, propamocarb
hydrochloride and Bacillus subtilis,
30 B-VII group: azaconazole, bitertanol, bromuconazole, climbazole, cyproconazole,
diclobutrazol, difenoconazole, diniconazole, diniconazole-M, epoxiconazole,
etaconazole, fenarimol, fenbuconazole, fluotrimazole, fluquinconazole, flusilazole,
flutriafol, furconazole, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole,
myclobutanil, nuarimol, oxpoconazole fumarate, pefurazoate, penconazole, prochloraz,
35 propiconazole, prothioconazole, pyrifenox, pyrisoxazole, simeconazole, tebuconazole,
tetraconazole, triadimefon, triadimenol, triflumizole, triforine, triticonazole, aldimorph,
D-3
N
(Z)n
D-7
N
N
(Z)n
D-10
N
S
(Z)n
D-32
N
(Z)n
E-5
O
E-9
O
O O
E-14
127
dodemorph acetate, fenpropidin, fenpropimorph, piperalin, spiroxamine, tridemorph,
fenhexamid and fenpyrazamine,
B-VIII group: validamycin, polyoxins, polyoxorim, benthiavalicarb-isopropyl,
dimethomorph, flumorph, iprovalicarb, mandipropamid, pyrimorph and valifenalate,
B-IX group: phthalide, pyroquilon, tricyclazole, carpropamid, diclocymet an5 d
fenoxanil,
B-X group: acibenzolar-S-methyl, probenazole, isotianil and tiadinil,
B-XI group: laminarin, bordeaux mixture, cheshunt mixture, copper carbonate
basic, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride,
10 copper sulfate, basic copper sulfate, oxine copper, calcium polysulfide, sulfur, amobam,
ferbam, mancozeb, maneb, metiram, polycarbamate, propineb, thiram, ziram, captan,
folpet, chlorothalonil, dichlofluanid, tolylfluanid, guazatine, iminoctadine-albesilate,
iminoctadine-triacetate, anilazine, dithianon, chinomethionat and fluoroimide,
B-XII group: cyflufenamid, cymoxanil, diclomezine, dodine, ferimzone, flusulfamide,
15 flutianil, fosetyl-aluminium, metrafenone, oxathiapiprolin, pyriofenone, tebufloquin,
tolprocarb, triazoxide, potassium hydrogen carbonate, sodium hydrogen carbonate,
shiitake mycelium extract, shiitake fruiting body extract, BCF-082 (test name) and NNF-
0721 (test name).
2. The composition for a fungicide, an insecticide, a nematicide or a bactericide
20 according to Claim 1, wherein
G1 represents a structure of G1-1, G1-2, G1-3, G1-7, G1-11, G1-12, G1-16, G1-27 or
G1-33,
G2 represents a structure of G2-1, G2-2 or G2-9,
W represents an oxygen atom,
25 X1 represents a halogen atom, methyl, difluoromethyl or trifluoromethyl,
X2 represents a hydrogen atom,
X3 represents a hydrogen atom or methyl,
X4 represents a hydrogen atom,
X5 represents a hydrogen atom,
30 Y1 represents a halogen atom,
Y2 represents a hydrogen atom, a halogen atom, methoxy, methylthio or
methylsulfonyl,
Y3 represents a halogen atom, trifluoromethyl, C2-C4 alkenyl, C2-C6 alkynyl, (C2-
C6) alkynyl optionally substituted by R6, C1-C4 haloalkoxy or -C(R8)=NOR9,
35 Y4 represents a hydrogen atom or a halogen atom,
Y5 represents a hydrogen atom,
R1 represents C1-C6 alkyl, C1-C4 haloalkyl, (C1-C4) alkyl substituted by R10, C3-C6
cycloalkyl, C3-C6 alkenyl, C3-C4 haloalkenyl or C3-C6 alkynyl,
R2 represents a hydrogen atom or methyl, provided that when G2 is a structure
40 represented by G2-1, R2 represents methyl,
R3 represents a hydrogen atom,
R4 represents a hydrogen atom,
R5 represents methyl,
R6 represents a halogen atom, C3-C6 cycloalkyl, -OR7, trimethylsilyl, -C(R8)=NOR9
45 or phenyl,
R7 represents C1-C4 alkyl or C1-C4 alkoxymethyl,
R10 represents C3-C6 cycloalkyl, trimethylsilyl, phenyl, phenyl substituted by (Z)m,
or D-32,
128
Z represents a halogen atom or cyano, and when m represents 2 or more, the
respective Z’s may be identical with or different from one another,
n represents an integer of 1.
3. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to Claim 1 or 2, wherei5 n
G1 represents a structure of G1-1, G1-3, G1-27 or G1-33,
G2 represents a structure of G2-2,
X1 represents a chlorine atom, an iodine atom, difluoromethyl or trifluoromethyl,
X2 represents a hydrogen atom,
10 X3 represents a hydrogen atom or methyl,
X4 represents a hydrogen atom,
X5 represents a hydrogen atom,
Y1 represents a chlorine atom or a bromine atom,
Y2 represents a hydrogen atom, a chlorine atom or methoxy,
15 Y3 represents a chlorine atom, a bromine atom, trifluoromethyl, C2-C6 alkynyl, or
(C2-C6) alkynyl optionally substituted by R6,
Y4 represents a hydrogen atom,
R1 represents C1-C4 alkyl, C1-C4 haloalkyl or cyclopropylmethyl,
R2 represents a hydrogen atom or methyl,
20 R3 represents a hydrogen atom,
R4 represents a hydrogen atom,
R5 represents methyl,
R6 represents a halogen atom, cyclopropyl or C1-C4 alkoxy.
4. The composition for a fungicide, an insecticide, a nematicide or a bactericide
25 according to any one of Claims 1 to 3, wherein
G1 represents a structure of G1-1,
X1 represents an iodine atom or trifluoromethyl,
X2, X3, X4 and X5 each represents a hydrogen atom.
5. The composition for a fungicide, an insecticide, a nematicide or a bactericide
30 according to any one of Claims 1 to 3, wherein
G1 represents a structure of G1-3,
X1 represents a chlorine atom or difluoromethyl,
X2, X3 and X4 each represents a hydrogen atom.
6. The composition for a fungicide, an insecticide, a nematicide or a bactericide
35 according to any one of Claims 1 to 3, wherein
G1 represents a structure of G1-27,
X1 represents difluoromethyl,
X2 represents a hydrogen atom,
R5 represents methyl.
40 7. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 3, wherein
G1 represents a structure of G1-33,
X1 represents difluoromethyl,
X3 represents methyl.
45 8. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-I group.
9. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-ll group.
10. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-lll group.
11. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-IV group.
12. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-V group.
13. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-VI group.
14. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-VII group.
15. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-VIII group.
16. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-IX group.
17. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-X group.
1S. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-XI group.
19. The composition for a fungicide, an insecticide, a nematicide or a bactericide
according to any one of Claims 1 to 7, which contains a compound selected from the
active ingredient B-XII group.
20. A method for controlling pests, noxious insects, nematodes or bacteria, by
treatment at the same time or in close temporal proximity with one or more compounds
selected from active ingredient A as defined in Claim 1 and one or more compounds
selected from active ingredient B as defined in Claim 1.
21. The method for controlling pests, noxious insects, nematodes or bacteria
according to Claim 20, wherein the application rate of each of active ingredient A and
active ingredient B is from 0.1 to 1,000 g a.i./ha.
22. The method for controlling pests, noxious insects, nematodes or bacteria
according to Claim 20 or 21, wherein the application dosage, as the amount of active
ingredients, is from 0.005 to 50 kg/ha.
| Section | Controller | Decision Date |
|---|---|---|
| # | Name | Date |
|---|---|---|
| 1 | 201617026364-Correspondence-041223.pdf | 2023-12-19 |
| 1 | Priority Document [02-08-2016(online)].pdf | 2016-08-02 |
| 2 | 201617026364-GPA-041223.pdf | 2023-12-19 |
| 2 | Form 5 [02-08-2016(online)].pdf | 2016-08-02 |
| 3 | Form 3 [02-08-2016(online)].pdf | 2016-08-02 |
| 3 | 201617026364-Others-041223.pdf | 2023-12-19 |
| 4 | Description(Complete) [02-08-2016(online)].pdf | 2016-08-02 |
| 4 | 201617026364-PROOF OF ALTERATION [01-11-2023(online)]-1.pdf | 2023-11-01 |
| 5 | Form 13 [05-08-2016(online)].pdf | 2016-08-05 |
| 5 | 201617026364-PROOF OF ALTERATION [01-11-2023(online)].pdf | 2023-11-01 |
| 6 | Description(Complete) [05-08-2016(online)].pdf | 2016-08-05 |
| 6 | 201617026364-RELEVANT DOCUMENTS [01-11-2023(online)].pdf | 2023-11-01 |
| 7 | 201617026364-Annexure [03-08-2022(online)].pdf | 2022-08-03 |
| 8 | abstract.jpg | 2016-09-01 |
| 8 | 201617026364-Response to office action [03-08-2022(online)].pdf | 2022-08-03 |
| 9 | 201617026364-IntimationOfGrant29-07-2022.pdf | 2022-07-29 |
| 9 | Other Patent Document [06-09-2016(online)].pdf | 2016-09-06 |
| 10 | 201617026364-PatentCertificate29-07-2022.pdf | 2022-07-29 |
| 10 | Form 26 [06-09-2016(online)].pdf | 2016-09-06 |
| 11 | 201617026364-Power of Attorney-090916.pdf | 2016-09-12 |
| 11 | 201617026364-Written submissions and relevant documents [12-04-2022(online)].pdf | 2022-04-12 |
| 12 | 201617026364-Correspondence to notify the Controller [29-03-2022(online)].pdf | 2022-03-29 |
| 12 | 201617026364-OTHERS-090916.pdf | 2016-09-12 |
| 13 | 201617026364-FORM-26 [25-03-2022(online)].pdf | 2022-03-25 |
| 13 | 201617026364-OTHERS-090916-.pdf | 2016-09-12 |
| 14 | 201617026364-Correspondence-090916.pdf | 2016-09-12 |
| 14 | 201617026364-US(14)-ExtendedHearingNotice-(HearingDate-29-03-2022).pdf | 2022-03-02 |
| 15 | 201617026364-CORRECTED PAGES [03-02-2022(online)].pdf | 2022-02-03 |
| 15 | 201617026364-Correspondence-090916-.pdf | 2016-09-12 |
| 16 | Other Patent Document [21-09-2016(online)].pdf | 2016-09-21 |
| 16 | 201617026364-MARKED COPY [03-02-2022(online)].pdf | 2022-02-03 |
| 17 | Form 3 [02-12-2016(online)].pdf | 2016-12-02 |
| 17 | 201617026364-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [04-12-2021(online)].pdf | 2021-12-04 |
| 18 | 201617026364-FORM 18 [08-12-2017(online)].pdf | 2017-12-08 |
| 18 | 201617026364-US(14)-HearingNotice-(HearingDate-03-01-2022).pdf | 2021-11-01 |
| 19 | 201617026364-ABSTRACT [21-10-2019(online)].pdf | 2019-10-21 |
| 19 | 201617026364-FER.pdf | 2019-05-14 |
| 20 | 201617026364-CLAIMS [21-10-2019(online)].pdf | 2019-10-21 |
| 20 | 201617026364-FORM 3 [23-09-2019(online)].pdf | 2019-09-23 |
| 21 | 201617026364-COMPLETE SPECIFICATION [21-10-2019(online)].pdf | 2019-10-21 |
| 21 | 201617026364-OTHERS [21-10-2019(online)].pdf | 2019-10-21 |
| 22 | 201617026364-CORRESPONDENCE [21-10-2019(online)].pdf | 2019-10-21 |
| 22 | 201617026364-FER_SER_REPLY [21-10-2019(online)].pdf | 2019-10-21 |
| 23 | 201617026364-CORRESPONDENCE [21-10-2019(online)].pdf | 2019-10-21 |
| 23 | 201617026364-FER_SER_REPLY [21-10-2019(online)].pdf | 2019-10-21 |
| 24 | 201617026364-COMPLETE SPECIFICATION [21-10-2019(online)].pdf | 2019-10-21 |
| 24 | 201617026364-OTHERS [21-10-2019(online)].pdf | 2019-10-21 |
| 25 | 201617026364-CLAIMS [21-10-2019(online)].pdf | 2019-10-21 |
| 25 | 201617026364-FORM 3 [23-09-2019(online)].pdf | 2019-09-23 |
| 26 | 201617026364-ABSTRACT [21-10-2019(online)].pdf | 2019-10-21 |
| 26 | 201617026364-FER.pdf | 2019-05-14 |
| 27 | 201617026364-FORM 18 [08-12-2017(online)].pdf | 2017-12-08 |
| 27 | 201617026364-US(14)-HearingNotice-(HearingDate-03-01-2022).pdf | 2021-11-01 |
| 28 | 201617026364-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [04-12-2021(online)].pdf | 2021-12-04 |
| 28 | Form 3 [02-12-2016(online)].pdf | 2016-12-02 |
| 29 | Other Patent Document [21-09-2016(online)].pdf | 2016-09-21 |
| 29 | 201617026364-MARKED COPY [03-02-2022(online)].pdf | 2022-02-03 |
| 30 | 201617026364-CORRECTED PAGES [03-02-2022(online)].pdf | 2022-02-03 |
| 30 | 201617026364-Correspondence-090916-.pdf | 2016-09-12 |
| 31 | 201617026364-Correspondence-090916.pdf | 2016-09-12 |
| 31 | 201617026364-US(14)-ExtendedHearingNotice-(HearingDate-29-03-2022).pdf | 2022-03-02 |
| 32 | 201617026364-FORM-26 [25-03-2022(online)].pdf | 2022-03-25 |
| 32 | 201617026364-OTHERS-090916-.pdf | 2016-09-12 |
| 33 | 201617026364-Correspondence to notify the Controller [29-03-2022(online)].pdf | 2022-03-29 |
| 33 | 201617026364-OTHERS-090916.pdf | 2016-09-12 |
| 34 | 201617026364-Written submissions and relevant documents [12-04-2022(online)].pdf | 2022-04-12 |
| 34 | 201617026364-Power of Attorney-090916.pdf | 2016-09-12 |
| 35 | 201617026364-PatentCertificate29-07-2022.pdf | 2022-07-29 |
| 35 | Form 26 [06-09-2016(online)].pdf | 2016-09-06 |
| 36 | 201617026364-IntimationOfGrant29-07-2022.pdf | 2022-07-29 |
| 36 | Other Patent Document [06-09-2016(online)].pdf | 2016-09-06 |
| 37 | 201617026364-Response to office action [03-08-2022(online)].pdf | 2022-08-03 |
| 37 | abstract.jpg | 2016-09-01 |
| 38 | 201617026364-Annexure [03-08-2022(online)].pdf | 2022-08-03 |
| 39 | 201617026364-RELEVANT DOCUMENTS [01-11-2023(online)].pdf | 2023-11-01 |
| 39 | Description(Complete) [05-08-2016(online)].pdf | 2016-08-05 |
| 40 | Form 13 [05-08-2016(online)].pdf | 2016-08-05 |
| 40 | 201617026364-PROOF OF ALTERATION [01-11-2023(online)].pdf | 2023-11-01 |
| 41 | Description(Complete) [02-08-2016(online)].pdf | 2016-08-02 |
| 41 | 201617026364-PROOF OF ALTERATION [01-11-2023(online)]-1.pdf | 2023-11-01 |
| 42 | Form 3 [02-08-2016(online)].pdf | 2016-08-02 |
| 42 | 201617026364-Others-041223.pdf | 2023-12-19 |
| 43 | Form 5 [02-08-2016(online)].pdf | 2016-08-02 |
| 43 | 201617026364-GPA-041223.pdf | 2023-12-19 |
| 44 | 201617026364-Correspondence-041223.pdf | 2023-12-19 |
| 44 | Priority Document [02-08-2016(online)].pdf | 2016-08-02 |
| 1 | 201617026364search_13-05-2019.pdf |